Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.65
Delayed Data
As of 4:00pm ET
 -0.04 / -2.37%
Today’s Change
1.10
Today|||52-Week Range
2.81
-32.65%
Year-to-Date
No recent news for Lineage Cell Therapeutics Inc.

Today’s Trading

Previous close1.69
Today’s open1.69
Day’s range1.64 - 1.75
Volume637,720
Average volume (3 months)903,958
Market cap$268.2M
Data as of 4:00pm ET, 07/06/2022

Growth & Valuation

Earnings growth (last year)-90.04%
Earnings growth (this year)+41.21%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+404.01%
P/E ratioNM
Price/Sales103.45
Price/Book2.90

Competitors

----
----
ALPNAlpine Immune Scienc...+0.22+2.46%
WVEWAVE Life Sciences L...+0.43+13.69%
Data as of 3:59pm ET, 07/06/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.9M
Annual profit (last year)-$43.0M
Net profit margin-1,104.18%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Carlsbad, California

Forecasts